Vanguard Group Inc

Holdings History for Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS)

Symbol: ACRS on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Ownership: 6.66M shares
Security Ownership: 6.15%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Aclaris Therapeutics, Inc. Common Stock, par value $0.00001 per share (ACRS)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.66M shares of Aclaris Therapeutics, Inc. Common Stock, par value $0.00001 per share (ACRS). This represents 6.15% percent ownership of the company. In their previous filing dated 2025-04-30, VANGUARD GROUP INC had reported owning 4.97M shares, indicating an increase of 34% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	6.15%	+31%	$10.2M	6.66M	+1,691,809	+34%	$1.53	13G	6/30/2025	29 Jul 2025 11:22:32
The Vanguard Group	4.6%		$7.6M	4.97M			$1.53	13G/A	3/31/2025	30 Apr 2025 10:53:25

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	0%	$12.4M	6.52M	-146,605	-2.2%	$1.90	Q3 2025
6/30/2025	0%	+0%	$9.46M	6.66M	+1,691,809	+34%	$1.42	Q2 2025
3/31/2025	0%	+0%	$7.6M	4.97M	+644,991		$1.53	Q1 2025
12/31/2024	0%	0%	$10.7M	4.33M	-360,235	-7.69%	$2.48	Q4 2024
9/30/2024	0%		$5.39M	4.69M	-2,053	-0.04%	$1.15	Q3 2024
6/30/2024	0%	0%	$5.16M	4.69M	-242,224	-4.91%	$1.10	Q2 2024
3/31/2024	0%	+0%	$6.11M	4.93M	+207,418	+4.39%	$1.24	Q1 2024
12/31/2023	0%	+0%	$4.96M	4.72M	+1,359,311	+40.4%	$1.05	Q4 2023
9/30/2023	0%	+0%	$23M	3.36M	+33,482	+1.01%	$6.85	Q3 2023
6/30/2023	0%	+0%	$34.5M	3.33M	+137,138	+4.3%	$10.37	Q2 2023
3/31/2023	0%	+0%	$25.8M	3.19M	+70,171	+2.25%	$8.09	Q1 2023
12/31/2022	0%	+0%	$49.2M	3.12M	+190,546	+6.5%	$15.75	Q4 2022
9/30/2022	0%	+0%	$46.1M	2.93M	+118,024	+4.19%	$15.74	Q3 2022
6/30/2022	0%	+0%	$39.3M	2.81M	+84,865	+3.11%	$13.96	Q2 2022
3/31/2022	0%	+0%	$47M	2.73M	+10,713	+0.39%	$17.24	Q1 2022
12/31/2021	0%	+0%	$39.5M	2.72M	+39,167	+1.46%	$14.54	Q4 2021
9/30/2021	0%	+0%	$48.2M	2.68M	+112,169	+4.37%	$18.00	Q3 2021
6/30/2021	0%	+0%	$45.1M	2.57M	+448,919	+21.2%	$17.56	Q2 2021
3/31/2021	0%		$53.4M	2.12M			$25.20	Q1 2021
12/31/2020	0%	+0%	$9.62M	1.49M	+185,983	+14.3%	$6.47^*	Q4 2020
9/30/2020	0%		$3.34M	1.3M	+295	+0.02%	$2.57^*	Q3 2020
6/30/2020	0%	0%	$2.11M	1.3M	-99,591	-7.11%	$1.62	Q2 2020
3/31/2020	0%	0%	$1.46M	1.4M	-11,479	-0.81%	$1.04	Q1 2020
12/31/2019	0%	+0%	$2.67M	1.41M	+36,090	+2.62%	$1.89	Q4 2019
9/30/2019	0%	0%	$1.49M	1.38M	-491,995	-26.3%	$1.08	Q3 2019
6/30/2019	0%	+0%	$4.09M	1.87M	+30,191	+1.64%	$2.19	Q2 2019
3/31/2019	0%	+0%	$11M	1.84M	+1,116,785	+155%	$5.99	Q1 2019
12/31/2018	0%	0%	$5.33M	721K	-468,312	-39.4%	$7.39	Q4 2018
9/30/2018	0%	0%	$17.3M	1.19M	-7,669	-0.64%	$14.52	Q3 2018
6/30/2018	0%	+0%	$23.9M	1.2M	+29,414	+2.52%	$19.97	Q2 2018
3/31/2018	0%	+0%	$20.5M	1.17M	+41,059	+3.65%	$17.52	Q1 2018
12/31/2017	0%	0%	$27.8M	1.13M	-57,504	-4.86%	$24.66	Q4 2017
9/30/2017	0%	+0%	$30.6M	1.18M	+371,556	+45.7%	$25.81	Q3 2017
6/30/2017	0%	+0%	$22M	812K	+100,799	+14.2%	$27.12	Q2 2017
3/31/2017	0%	+0%	$21.2M	712K	+106,303	+17.6%	$29.82	Q1 2017
12/31/2016	0%	+0%	$16.4M	605K	+179,729	+42.2%	$27.14	Q4 2016
9/30/2016	0%	+0%	$10.9M	425K	+6,303	+1.5%	$25.61	Q3 2016
6/30/2016	0%	+0%	$7.74M	419K	+249,888	+148%	$18.47	Q2 2016
3/31/2016	0%	+0%	$3.21M	169K	+19,308	+12.9%	$18.95	Q1 2016
12/31/2015	0%	+0%	$4.04M	150K	+149,988	NEW	$26.94	Q4 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.